Financial Health Assessment: SURE24 LIMITED

1. Financial Health Score: C+

Explanation: SURE24 LIMITED presents a mixed health picture – like a patient with a strong constitution but showing concerning vital sign deterioration. While the company remains solvent with positive net assets and is actively investing in growth, there are significant symptoms of cash flow strain. The dramatic decline in cash reserves, coupled with ballooning debtors and current liabilities, suggests the business is experiencing growing pains that require urgent attention before they become chronic conditions.

2. Key Vital Signs

Net Assets: £780,315 (2024) vs £727,940 (2023)

📈 +7.2% increase – This is a positive sign, indicating the business is retaining profits and building equity. Think of net assets as the company's "bone density" – it's strengthening, which is good. However, this growth is modest compared to the significant increase in total assets, suggesting the expansion is heavily debt-financed.

Cash Position: £135,568 (2024) vs £258,501 (2023)

📉 -47.5% decrease – This is the most alarming vital sign. Cash is the "blood pressure" of any business, and this represents a significant drop. More concerning is the longer-term trend: cash has fallen from £766,061 in 2021 to just £135,568 today – an 82% decline over three years. The company is haemorrhaging cash despite growing its asset base.

Current Ratio: 1.45:1 (2024) vs 1.83:1 (2023)

📉 Deteriorating – While still above 1.0 (meaning current assets exceed current liabilities), this ratio has fallen significantly. Think of this as the company's "immune system" – it's weakening. A current ratio below 1.5 for a manufacturing business raises questions about short-term financial resilience.

Quick Ratio (Acid Test): 0.92:1 (2024) vs 0.95:1 (2023)

⚠️ Below 1.0 – Excluding stock, the company cannot cover its current liabilities with its liquid assets. This is like having insufficient reserves to fight off an infection – if creditors demanded payment urgently, the company would struggle without selling stock, potentially at discounted prices.

Debtors: £1,055,828 (2024) vs £560,630 (2023)

📈 +88.3% increase – Trade debtors nearly doubled from £312,865 to £617,633. This is a "blocked artery" symptom – money is owed to the business but isn't flowing in. This could indicate: - Aggressive sales growth with extended payment terms - Deteriorating customer payment behaviour - Potential bad debt risk that hasn't been provided for

Current Liabilities: £1,297,733 (2024) vs £861,434 (2023)

📈 +50.6% increase – A significant jump, primarily driven by: - Trade creditors up 27% (£558,736 → £709,686) – the company is stretching supplier payments - Taxation and social security up 284% (£129,507 → £497,951) – a massive increase suggesting either profitability or delayed tax payments

Stock Levels: £685,328 (2024) vs £757,562 (2023)

📉 -9.5% decrease – Slightly lower stock, which isn't necessarily bad. However, stock still represents 36.5% of current assets, meaning over a third of short-term assets are tied up in inventory.

3. Diagnosis

Primary Condition: Cash Flow Constriction Despite Asset Growth

SURE24 LIMITED is experiencing what I'd term "financial hypertension" – the business is growing (assets up 30.7% year-on-year, employees up from 19 to 29), but the circulatory system (cash flow) is under severe strain.

Key Findings:

1. The Growth-Cash Paradox: Total assets grew from £1.6M to £2.1M, yet cash fell by nearly half. This suggests the company is growing faster than its cash generation can support – like a teenager experiencing a growth spurt that outpaces their calorie intake.

2. Debtors Are Clogging the System: With debtors nearly doubling, the company is effectively acting as a bank for its customers. This £1M+ tied up in receivables represents a significant opportunity cost and collection risk.

3. Intangible Asset Investment: The addition of £186,091 in intangible assets (likely development costs or patents) shows strategic investment, but this has been funded from operating cash flow rather than external financing, contributing to the cash drain.

4. Tax Liability Surge: The 284% increase in taxation and social security liabilities could indicate either: - Strong profitability (positive) - Timing differences in tax payments (neutral) - Potential cash flow pressure when these become due (concerning)

5. Parent Company Cross-Guarantee: The company has cross-guaranteed a loan in its parent company (Newbrick Group 4 Ltd), secured by a fixed and floating charge over SURE24's property and undertakings. This is a significant risk factor – like co-signing a loan for a family member, it exposes the company to risks outside its direct control.

6. Long-term Trend Concern: Net assets peaked at £1.27M in 2021, dropped to £752K in 2022, and have only recovered to £780K in 2024. The company hasn't regained its 2021 financial health despite significant asset growth.

4. Recommendations

Immediate Actions (Urgent – Next 30 Days)

1. Debtors Recovery Programme: With £1M+ outstanding, implement an immediate credit control review. Consider: - Ageing analysis to identify overdue accounts - Escalated collection procedures for balances over 60 days - Potential offering of early payment discounts (2-3%) to accelerate cash inflow - Review credit terms offered to new customers

2. Cash Flow Forecasting: Develop a 13-week rolling cash flow forecast to identify potential "cardiac arrest" moments where cash might run out. This should account for the large tax liability coming due.

3. Review Tax Position: Clarify with advisors whether the £497,951 tax liability is current or deferred, and when payment is due. If this represents Corporation Tax, ensure funds are ring-fenced for payment.

Short-term Actions (Next 90 Days)

4. Working Capital Optimisation: - Negotiate extended payment terms with suppliers (currently averaging around 30-45 days based on creditor levels) - Consider invoice financing to unlock the £617K in trade debtors - Review stock management for slow-moving items

5. Review Parent Company Arrangements: Understand and document the implications of the cross-guarantee with Newbrick Group 4 Ltd. Ensure the board is aware of the contingent liability this creates.

Medium-term Actions (Next 6-12 Months)

6. Funding Strategy: Given the growth trajectory, consider whether external funding (overdraft facility, asset finance, or equity) would be appropriate to support the working capital cycle rather than relying solely on internal cash generation.

7. Intangible Asset Commercialisation: The £186K investment in intangible assets should be generating returns. Develop clear monetisation strategies for these assets to justify the investment and improve cash generation.

8. Key Performance Indicators: Implement regular monitoring of: - Debtor days (target: below 45 days) - Cash conversion cycle - Current ratio (target: above 1.5) - Quick ratio (target: above 1.0)

Prognosis

Cautiously Optimistic with Vigilance Required

SURE24 LIMITED is not in immediate danger of insolvency – it has positive net assets, a current ratio above 1, and is clearly a growing business. However, the trajectory of declining cash and increasing short-term liabilities is unsustainable without intervention.

If the debtor collection and cash management recommendations are implemented effectively, the company should be able to stabilise its "blood pressure" and continue its growth trajectory. The investment in intangible assets and employee expansion suggests management has confidence in future revenue generation.

The primary risk factors are: - The cross-guarantee with the parent company - Potential bad debts within the £1M+ debtor book - The ability to convert growth into cash rather than just paper assets

With appropriate financial discipline and working capital management, this business can return to a healthier state. Without it, the cash position could deteriorate to a critical level within 12-18 months.